Unknown

Dataset Information

0

Improving PMTCT uptake and retention services through novel approaches in peer-based family-supported care in the clinic and community: a 3-arm cluster randomized trial (PURE Malawi).


ABSTRACT: In July 2011, Malawi introduced an ambitious public health program known as "Option B+," which provides all HIV-infected pregnant and breastfeeding women with lifelong combination antiretroviral therapy, regardless of clinical stage or CD4 count. Option B+ is expected to have benefits for HIV-infected women, their HIV-exposed infants, and their HIV-uninfected male sex partners. However, these benefits hinge on early uptake of prevention of mother-to-child transmission, good adherence, and long-term retention in care. The Prevention of mother-to-child transmission Uptake and REtention (PURE) study is a 3-arm cluster randomized controlled trial to evaluate whether clinic- or community-based peer support will improve care-seeking and retention in care by HIV-infected pregnant and breastfeeding women, their HIV-exposed infants, and their male sex partners, and ultimately improve health outcomes in all 3 populations. We describe the PURE Malawi Consortium, the initial work conducted to inform the trial and interventions, the trial design, and the analysis plan. We then discuss concerns and expected contributions to Malawi and the region.

SUBMITTER: Rosenberg NE 

PROVIDER: S-EPMC4197136 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Improving PMTCT uptake and retention services through novel approaches in peer-based family-supported care in the clinic and community: a 3-arm cluster randomized trial (PURE Malawi).

Rosenberg Nora E NE   van Lettow Monique M   Tweya Hannock H   Kapito-Tembo Atupele A   Bourdon Cassandre Man CM   Cataldo Fabian F   Chiwaula Levison L   Sampathkumar Veena V   Trapence Clement C   Kayoyo Virginia V   Kasende Florence F   Kaunda Blessings B   Speight Colin C   Schouten Erik E   Eliya Michael M   Hosseinipour Mina M   Phiri Sam S  

Journal of acquired immune deficiency syndromes (1999) 20141101


In July 2011, Malawi introduced an ambitious public health program known as "Option B+," which provides all HIV-infected pregnant and breastfeeding women with lifelong combination antiretroviral therapy, regardless of clinical stage or CD4 count. Option B+ is expected to have benefits for HIV-infected women, their HIV-exposed infants, and their HIV-uninfected male sex partners. However, these benefits hinge on early uptake of prevention of mother-to-child transmission, good adherence, and long-t  ...[more]

Similar Datasets

| S-EPMC5504621 | biostudies-literature
| S-EPMC5268132 | biostudies-literature
| S-EPMC8011175 | biostudies-literature
| S-EPMC7543052 | biostudies-literature
| S-EPMC5489256 | biostudies-literature
| S-EPMC4724424 | biostudies-literature
| S-EPMC8048322 | biostudies-literature
| S-EPMC5736203 | biostudies-literature
| S-EPMC7275352 | biostudies-literature
| S-EPMC8186790 | biostudies-literature